Get Started Sign In

About Us

News & Press Releases

Procured Health to Discuss Using Clinical Evidence to Reduce Costs, Improve Patient Care at AHRMM17

CHICAGO, IL (July 25, 2017) –  John Cherf, MD, MPH, MBA, chief of orthopedics at Advocate Illinois Masonic Medical Center, and Julie Schulz, MD, MPH, Procured Health vice president, will present “Leveraging Evidence-Based Medicine to Reduce Clinical Costs and Improve Outcomes” on Wednesday, July 26, at the AHRMM17 Conference in... Read more » read more

Guthrie Adopts Procured Health’s Full Solution Suite to Reduce Clinical Supply Spend Across the System

CHICAGO, IL (July 12, 2017) – Guthrie, an integrated health system with subspecialty and primary care sites in 22 communities throughout Pennsylvania and New York, announced that it would be adopting Procured Health’s full solution suite to reduce clinical supply spend as part of its ongoing initiatives to optimize performance across the... Read more » read more

Procured Health Appoints Michael Blaszyk as Board Member and Egon Doppenberg, MD, as Physician Advisor

Chicago, IL (June  15, 2017) – Procured Health, a leader in providing health systems with solutions that improve patient outcomes and operational efficiency, announced two key appointments today. Michael Blaszyk will join the firm’s board of directors while Egon Doppenberg, MD, will serve on the company’s Physician Advisory Council. Blaszyk brings... Read more » read more

Procured Health Introduces Market Insights to Drive Evidence-Based Medical Product Spending and Utilization

Chicago, IL (May 18, 2017) – Procured Health, a leader in providing health systems with solutions that improve both patient outcomes and operational efficiency, announced the addition of Market Insights to its cloud-based Analytics application. With Market Insights, health systems can for the first time combine clinical evidence with market... Read more » read more

Biosimilars: Disruption or Disappointment?

In a recent blog post, Allison Wu asks whether biosimilars are a disruption or a disappointment? Branded as “Inflectra”, this form of infliximab is developed by Celltrion and will be co-marketed by Pfizer. Despite steadily rising interest in biosimilars over the past 5 years, Inflectra is only the second true biosimilar drug... Read more » read more

Procured Health Reports Record Growth for Second Consecutive Year

CHICAGO, IL – January 31, 2017 – Procured Health, a leading provider of technology applications that enable health systems and physicians to align practice with clinical evidence, announced today that it achieved record growth in 2016 for the second consecutive year. In addition, their customers achieved more than $70M in... Read more » read more

Is Over-diagnosis, Over-treatment, or Over-prescribing Ailing You?

In a recent blog post by Gina Thomas, RN, MBA, Chief Development Officer of Procured Health asks is over-diagnosis, over-treatment, or over-prescribing ailing you? With healthcare costs 18% of GDP and wastes in healthcare costs such as overtreatment escalating to heights over $130 billion, our society of convenience and demand to ‘fix me now’ may be causing... Read more » read more

An Inside Look at Cardiovascular Technology

A recently published whitepaper on Rapid Innovation in Cardiovascular Technology: explores the clinical evidence in three cardiovascular devices Before selecting any clinical treatment or modality, a comprehensive and also unbiased review and understanding of the clinical evidence is critical for the best patient outcomes. Three examples of innovative technology and the leading... Read more » read more

Cost is King: 5 Thoughts On the Hospital Supply Chain from an Expert Who’s Seen Both Sides of the Business

In the realm of the hospital supply chain, cost dictates all. And cost is more relevant than ever in healthcare right now, said John Cunningham, chief solutions officer at Procured Health. “Almost every organization I’ve worked with has given their supply chain department a specific savings target to help maintain costs.” Mr. Cunningham... Read more » read more

How Metric-Driven Decisions Can Bring ‘Revolutionary Innovation’ Back to Healthcare

There’s a perception among physicians that the medical innovation field is stagnating. Major companies horizontally innovate on their groundbreaking devices and investor money is leaving for greener pastures. But small manufacturers and tech companies are looking to change that. They just need a little help. Julie Schulz, MD, MPH, and... Read more » read more

Categories

Complimentary Access to Lumere's Solutions
Tackle unwarranted variation across drugs and devices. 
Yes, our team would like access.
No thanks. Our value analysis teams and P&T committees are not currently working to cut costs or improve outcomes.